3.25
price down icon0.61%   -0.02
after-market Handel nachbörslich: 3.22 -0.03 -0.92%
loading

Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
0.03%
14.82
14.82 14.83 14.66 42.73
Operating Income/Loss
0.03%
-14.82
-14.82 -14.83 -14.66 -42.73
Income/Loss From Continuing Operations Before Tax
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Income/Loss From Continuing Operations After Tax
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Net Income/Loss
10.87%
-13.82
-12.46 -13.70 -13.39 -41.86
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,125%
27.01
2.2047 26.99 14.71 129.34
Diluted Average Shares
1,125%
27.01
2.2047 26.99 14.71 129.34
Basic Earnings Per Share
155.00%
-0.51
-0.20 -0.51 -0.91 -0.32
Diluted Earnings Per Share
155.00%
-0.51
-0.20 -0.51 -0.91 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.76
price down icon 4.64%
$80.58
price down icon 1.17%
$43.47
price up icon 1.68%
$400.87
price up icon 0.11%
$193.64
price down icon 5.56%
$106.32
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):